• Explore /
  • Poster
  • / Trial in progress: A phase II, multicenter, open-label study of PolyPEPI1018 in combination with atezolizumab in participants with relapsed or refractory microsatellite-stable metastatic colorectal (MSS mCRC) cancer (Oberto-301).

Trial in progress: A phase II, multicenter, open-label study of PolyPEPI1018 in combination with atezolizumab in participants with relapsed or refractory microsatellite-stable metastatic colorectal (MSS mCRC) cancer (Oberto-301).

Abstract Poster

Authors

Joleen Hubbard

Joleen M. Hubbard

Mayo Clinic, Rochester, MN;

Joleen M. Hubbard , Daniel H. Ahn , Jeremy Clifton Jones , Kathleen Wittenberger , Levente Molnar , Orsolya Lorincz , Eszter Somogyi , Zsolt Csiszovszki , Hagop Youssoufian , Eniko Rita Toke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05243862

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS283)

DOI

10.1200/JCO.2023.41.4_suppl.TPS283

Abstract #

TPS283

Poster Bd #

Q5

Abstract Disclosures

Similar Posters

First Author: Dale Randall Shepard

First Author: Marwan Fakih

First Author: Luis A. Diaz Jr.

First Author: Dung T. Le